Advances in autoantibodies in SLE

Hargraves MM , Richmond H , Morton R . Presentation of two bone marrow elements: The ‘tart’ cells and the ‘L.E.’ cell . Mayo Clin Proc 1948; 27: 25–28 .

Holman HR , Kunkel HG . Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein . Science 1957; 126: 162–163 .

Friou GJ . Identification of the nuclear component of the interaction of lupus erythematosus globulin and nuclei . J Immunol 1958; 80: 476–481 .

Rekvig OP , Hannestad K . Lupus erythematosus (LE) factors recognize both nucleosomes and viable human leucocytes . Scand J Immunol 1981; 13: 597–604 .

Holborow EJ , Weir DM . HistoneL an essential component for the lupus erythematosus antinuclear reaction . Lancet 1959; 1: 809–810 .

Fritzler MJ . Clinical relevance of autoantibodies in systemic rheumatic diseases . Mol Biol Rep 1996; 23: 133–145 .

von Muhlen CA , Tan EM . Autoantibodies in the diagnosis of systemic rheumatic disease . Semin Arthritis Rheum 1995; 24: 323–358 .

Tan EM . Autoantibodies and autoimmunity: A three-decade perspective—A tribute to Henry G Kunkel . Ann NY Acad Sci 1997; 815: 1–14 .

Farquhar MG , Palade GE . The Golgi apparatus: 100 years of progress and controversy . Trends Cell Biol 1998; 8: 2–10 .

Mazzarello P , Bentivoglio M . The centenarian Golgi apparatus . Nature 1998; 392: 543–544 .

Fritzler MJ , Hamel JC , Ochs RL , Chan EKL . Molecular characterization of two human autoantigens: Unique cDNAs encoding 95-and 160-kD protein of a putative family in the Golgi complex . J Exp Med 1993; 178: 49–62 .

Nakamura N et al. Characterization of cis-Golgi matrix protein, GM130 . J Cell Biol 1995; 131: 1715–1726 .

Nakamura N et al. The vesicle docking protein p115 binds GM130, a cis-Golgi matrix protein, in a mitotically regulated manner . Cell 1997; 89: 445–455 .

Seelig MP et al. Macrogolgin-A new 376 kD Golgi complex outer membrane protein as target of antibodies in patients with rheumatic diseases and HIV infections . J Autoimmun 1994; 7: 67–91 .

Lindstedt AD , Hauri HP . Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa . Mol Biol Cell 1993; 4: 679–693 .

Seelig HP et al. Molecular genetic analyses of a 376-kilodalton Golgi complex membrane protein (Giantin) . Mol Cell Biol 1994; 14: 2564–2576 .

Sohda M et al. Molecular cloning and sequence analysis of a human 372-kDa protein localized in the Golgi complex . Biochem Biophys Res Commun 1994; 205: 1399–1408 .

Toki C et al. Identification and characterization of rat 364-kDa Golgiassociated protein recognized by autoantibodies from a patient with rheumatoid arthritis . Cell Struct Func 1997; 22: 565–577 .

Sonnichsen B et al. A role for giantin in docking COPI vesicles to Golgi membranes . J Cell Biol 1998; 140: 1013–1021 .

Fritzler MJ et al. Molecular characterization of golgin-245: A novel Golgi complex protein containing a granin signature . J Biol Chem 1995; 270: 31262–31268 .

Erlich R et al. Molecular characterization of trans-Golgi p230 . J Biol Chem 1996; 271: 8328–8337 .

Griffith KN et al. Molecular characterization of a novel 97 kDa Golgi complex autoantigen recognized by autoimmune antibodies from patients with Sjögren's syndrome . Arthritis Rheum 1997; 40: 693–702 .

Renier G , Fritzler MJ , Chevailler MD . Golgi apparatus autoantibodies. In: Peter JB , Shoenfeld Y (eds) Autoantibodies. Elsevier: Amsterdam, Lausanne, New York, Oxford, Shannon, Tokyo . 1996; pp 325–330.

Vassalli JD , Sappino AP , Belin D . The plasminogen activator/plasmin system . J Clin Invest 1991; 88: 1067–1072 .

Angles-Cano E , Sultan Y , Clauvel JP . Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage . J Lab Clin Med 1979; 94: 312–323 .

Hart DA , Fritzler MJ . Regulation of plasminogen activators and their inhibitors in rheumatic diseases: new understanding and the potential for new directions . J Rheumatol 1989; 16: 1184–1191 .

Mosesson MW . Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly . Blood Coagul Fibrinolysis 1997; 8: 257–267 .

Ploug M , Beherent N , Dano K . Protein stucture and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator . Sem Thromb Haemost 1991; 17: 183–193 .

Fleury V , Angles-Cano E . Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines . Biochemistry 1991; 30: 7630–7638 .

Miles LA et al. Roel of cell surface lysine in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor . Biochemistry 1991; 30: 1682–1691 .

Salazar-Paramo M et al. Antibodies to fibrin-bound tissue type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis . Lupus 1996; 5: 275–278 .

Fritzler MJ et al. Antibodies to fibrin-bound tissue-type plasminogen activator in systemic sclerosis . J Rheumatol 1995; 22: 1688–1693 .

Morse JH et al. Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7 . Am J Respir Crit Care Med 1997; 155: 274–278 .

Craft J , Fatenejad S . Self antigens and epitope spreading in systemic autoimmunity . Arthritis Rheum 1997; 40: 1374–1382 .

James JA , Gross T , Scofield RH , Harley JB . Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: sm B/B0-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity . J Exp Med 1995; 181: 453–461 .

Topfer F , Gordon T , McCluskey J . Intra-and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A) . Proc Natl Acad Sci USA 1995; 92: 875–879 .

McRae BL , Vanderlugt CL , Dal Canto MC , Miller SD . Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis . J Exp Med 1995; 182: 75–85 .

Vlase H et al. Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: Evidence for intramolecular epitope spreading . Endocrinology 1995; 136: 4415–4423 .

Tseng CE et al. The 52-kd protein as a target of intermolecular spreading of the immune response to components of the SS-A/Ro-SSB/La complex . Arthritis Rheum 1997; 40: 936–944 .

Craft J , Hardin JA . Linked sets of antinuclear antibodies: what do they mean? J Rheumatol 1987; 14 (suppl.): 106–109 .

Northway JS , Tan EM . Differentiation of antinuclear antibodies giving speckled staining patterns in immunofluorescence . Clin Immunol Immunopathol 1972; 1: 140–154 .

Mattioli M , Reichlin M . Physical association of two nuclear antigens and mutal occurrence of their antibodies: the relationships of the Sm and RNA protein (Mo) systems in SLE sera . J Immunol 1973; 110: 1318–1324 .

Clarke S , Stephenson RC , Lowenson JD . Lability of asparagine and aspartic acid residues in proteins and peptides. In: Ahern TJ , Manning MC (eds). Stability of Protein Pharmaceuticals. New York: Plenum Press , 1992.

Roher AE , Lowenson JD , Clarke S . Structural alterations in the peptide backbone of b-amyloid core protein may account for its deposition and stability in Alzheimer's disease . J Biol Chem 1993; 268: 3072–3083 .

Kuragaki C , Kidoguchi K , Nakamura N , Wada Y . Anti-annexin V antibodies in plasma and serum samples from patients with lupus anticoagulant . Am J Hematol 1995; 50: 68–68 .

Nakamura N et al. Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties . Am J Hematol 1995; 49: 347–348 .

Merrill JT , Rivkin E , Shen C , Lahita RG . Selection of a gene for apolipoprotine A1 using autoantibodies from a patient with systemic lupus erythematosus . Arthritis Rheum 1995; 38: 1655–1659 .

Utz PJ , Hottelet M , Schur PH , Anderson P . Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus . J Exp Med 1997; 185: 843–854 .

Blomberg J et al. Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus . Arthritis Rheum 1994; 37: 57–66 .

Bengtsson A et al. Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus erythematosus . Arthritis Rheum 1996; 39: 1654–1663 .

Ordi-Ros J , Paredes J , Detarsio G , Vilardell M . Autoantibodies to C1 inhibitor in patients with lupus disease [letter] . J Rheumatol 1997; 24: 1856–1858 .

Ronnelid J , Gunnarsson I , Nilsson-Ekdahl K , Nilsson B . Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA . J Autoimmun 1997; 10: 415–423 .

Ravelli A et al. IgG autoantibodies to complement C1q in pediatriconset systemic lupus erythematosus . Clin Exp Rheumatol 1997; 15: 215–219 .

Sjoholm AG , Martensson U , Sturfelt G . Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus . J Rheumatol 1997; 24: 871–878 .

Eggleton P , Reid KBM , Kishore U , Sontheimer RD . Clinical relevance of calreticulin in systemic lupus erythematosus . Lupus 1997; 6: 564–571 .

Kishore U et al. The systemic lupus erythematosus (SLE) disease autoantigen—Calreticulin inhibit C1q association with immune complexes . Clin Exp Immunol 1997; 108: 181–190 .

al-Shahi R et al. Systemic lupus erythematosus, thrombocytopenia, microangiopathic haemolytic anaemia and anti-CD36 antibodies [clinical conference] . Br J Rheumatol 1997; 36: 794–798 .

Lenert G , Lenert P . Human CD4-reactive antibodies from SLE patients induce reversible inhibition of polyclonal T lymphocyte proliferation . Hum Immunol 1996; 49: 113–121 .

Czyzyk J , Fernsten P , Shaw M , Winfield JB . Cell-type specificity of anti-CD45 autoantibodies in systemic lupus erythematosus . Arthritis Rheum 1996; 39: 592–599 .

Atta MS et al. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus . Ann Rheum Dis 1995; 54: 117–124 .

Arnett FC , Reveille JD , Valdez BC . Autoantibodies to a nucleolar RNA helicase protein in patients with connective tissue disease . Arthritis Rheum 1997; 40: 1487–1492 .

Valdez BC , Henning D , Perumal K , Busch H . RNA-unwinding and RNA-folding activities of RNA helicase II Gu—Two activities in separate domains of the same protein . Eur J Biochem 1997; 250: 800–807 .

Perl A et al. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes—Correlation with antinuclear antibodies and HLA class II alleles . Arthritis Rheum 1995; 38: 1660–1671 .

Moller DE , Ratner RE , Borenstein DG , Taylor SI . Autoantibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosus . Am J Med 1988; 84: 334–338 .

Dicou E , Nerriere V . Evidence that natural autoantibodies against the nerve growth factor (NGF) may be potential carriers of NGF . J Neuroimmunol 1997; 75: 200–203 .

Kovacs B et al. Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseases . Arthritis Rheum 1997; 40: 980–985 .

Marguerie C et al. Anti-PL 4 in patients with systemic lupus erythematosus with severe renal and haematological disease . Quart J Med 1997; 90: 347–352 .

Macchi L et al. Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia . Br J Haematol 1997; 98: 336–341 .

Feist E et al. Proteasone a-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus . J Exp Med 1996; 184: 1313–1318 .

Bertolaccini ML et al. Autoantibodies to human prothrombin and clinical manifestations in 207 Patients with systemic lupus erythematosus . J Rheumatol 1998; 25: 1104–1108 .

Cai Y et al. Autoantibody reactive with the human general transcription factor TFIIF in sera from patients with autoimmune disorders . Clin Exp Immunol 1997; 109: 488–494 .

Garcia-Lozano R et al. Presence of antibodies to different subunits of replication protein A in autoimmune sera . Proc Natl Acad Sci USA 1995; 92: 5116–5120 .

Garcia-Lozano R et al. Presence of antibodies to replication protein A in some patients with systemic lupus erythematosus (SLE) . Clin Exp Immunol 1996; 103: 74–76 .

Whitehead CM , Winkfein RJ , Fritzler MJ , Rattner JB . The spindle kinesin-like protein HsEg5 is an autoantigen in systemic lupus erythematosus (SLE) . Arthritis Rheum 1996; 39: 1635–1642 .

Andrade LEC , Chan EKL , Peebles CL , Tan EM . Two major autoantigen–antibody systems of the mitotic spindle apparatus . Arthritis Rheum 1996; 39: 1643–1653 .

Whitehead CM , Fritzler MJ , Rattner JB . The relationship of ASE-1 and NOR-90 in autoimmune sera. J Rheumatol 1998; in press.

Conroy SE et al. Autoantibodies to 90 kD heat-shock protein in sera of breast cancer patients . Lancet 1995; 354: 126–126 .

Jarjour WN et al. Autoantibodies to human stress proteins. A survey of various rheumatic and other inflammatory diseases . Arthritis Rheum 1991; 34: 1133–1139 .

Winfield J , Jarjour W . Stress proteins in autoimmunity . Adv Exp Med Biol 1994; 347: 99–113 .

Paul S et al. Characterization of thyroglobulin-directed and polyreactive catalytic antibodies in autoimmune disease . J Immunol 1997; 159: 1530–1536 .

Satoh T et al. Systemic lupus erythematosus associated with autoimmune hepatitis two cases with novel autoantibodies to transfer RNA-related antigens . Clin Rheumatol 1997; 16: 305–309 .